Related Experiment Video
Updated: Jul 13, 2026
09:11
Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Isotretinoin: an Indian experience
1B-708, Rainbow, Raheja Vihar, Powai, Mumbai-400072, Maharashtra, India.
Indian Journal of Dermatology, Venereology and Leprology
|August 1, 2007
Summary
Isotretinoin is a groundbreaking oral retinoid treatment for severe skin disorders like recalcitrant acne vulgaris. This study confirms its unique efficacy and evaluates potential side effects, highlighting its significant therapeutic impact.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Severe skin disorders, such as recalcitrant acne vulgaris, can have profound emotional, physical, and psychological impacts.
- Isotretinoin has emerged as a potential milestone treatment in dermatotherapeutics.
Purpose of the Study:
- To retrospectively analyze the efficacy of isotretinoin.
- To evaluate the incidence of potentially significant side effects associated with isotretinoin therapy.
Main Methods:
- Retrospective analysis of patient data.
- Evaluation of treatment outcomes and adverse events.
Main Results:
- Isotretinoin demonstrates unique efficacy in treating various skin disorders.
- The study assessed the occurrence of significant side effects related to isotretinoin use.
Conclusions:
- Oral retinoids, specifically isotretinoin, offer unparalleled therapeutic benefits for specific skin conditions.
- Isotretinoin is a crucial option for managing debilitating skin disorders like recalcitrant acne vulgaris.
Related Concept Videos
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:17Drug Absorption: Overview
The process of drug absorption signifies the transition of a drug from its site of administration into the plasma. This process is influenced by various factors, including the route of administration, the anatomy of the absorption site, the mechanism of absorption, gut motility, and the drug's physicochemical properties.
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI) tract.
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI) tract.
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...